Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Symptoms Related to Tumor Necrosis Factor Receptor 1-associated Periodic Syndrome, Multiple Sclerosis, and Severe Rheumatoid Arthritis in Patients Carrying the TNF Receptor Superfamily 1A D12E/p.Asp41Glu Mutation.
Current and emerging therapies for multiple sclerosis.
The Neurite Outgrowth Inhibitory Nogo-A-Δ20 Region Is an Intrinsically Disordered Segment Harbouring Three Stretches with Helical Propensity.
Restless legs syndrome in Iranian multiple sclerosis patients: a case-control study.
Dalfampridine: review of its efficacy in improving gait in patients with multiple sclerosis.
Does robot-assisted gait training ameliorate gait abnormalities in multiple sclerosis? A pilot randomized-control trial.
'Spinal amaurosis' (1841). On the early contribution of Edward Hocken to the concept of neuromyelitis optica.
Multiple Sclerosis.
HDAC1/2-Dependent P0 Expression Maintains Paranodal and Nodal Integrity Independently of Myelin Stability through Interactions with Neurofascins.
Update in vitamin D and multiple sclerosis.
Antibodies to MOG in NMO: A seasoned veteran finds a new role.
Intractable pruritus in neuromyelitis optica.
Effect of a 2-week trial of functional electrical stimulation on gait function and quality of life in people with multiple sclerosis.
Normatization of the symbol digit modalities test-oral version in a latin american country.
Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs.
Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases.
Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
Managed care aspects of managing neurogenic bladder/neurogenic detrusor overactivity.
The RESTORE trial: What did we learn about multiple sclerosis?
Autoantibodies in pre-clinical autoimmune disease.
Dock3 protects myelin in the cuprizone model for demyelination.
Age-related Shift in Neural Complexity Related to Task Performance and Physical Activity.
Antibodies against interferon-beta in neuromyelitis optica patients.
Multiple sclerosis: Could simvastatin slow down secondary progressive MS?
Pages
« first
‹ previous
…
459
460
461
462
463
464
465
466
467
…
next ›
last »